Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)P. R. Lichtlen, Jaap W. Deckers, Peter Nikutta et al.|Cardiovascular Drugs and Therapy|1990Cited by 93